加巴喷丁治疗特发性咳嗽疗效的队列描述与分析。

Charlotte Van de Kerkhove, Pieter C Goeminne, Pascal Van Bleyenbergh, Lieven J Dupont
{"title":"加巴喷丁治疗特发性咳嗽疗效的队列描述与分析。","authors":"Charlotte Van de Kerkhove,&nbsp;Pieter C Goeminne,&nbsp;Pascal Van Bleyenbergh,&nbsp;Lieven J Dupont","doi":"10.1186/1745-9974-8-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Unlabelled: </strong></p><p><strong>Background: </strong>Chronic idiopathic cough (known as cough hypersensitivity syndrome) is defined by cough in the absence of an identifiable cause. Gabapentin has been suggested as a treatment but evidence is scarce. The aim of our study was to describe the clinical features of patients with unexplained chronic cough and to investigate the effect of gabapentin (600 mg twice a day for a minimal duration of 4 weeks) in reducing cough symptoms.</p><p><strong>Methods: </strong>A patient cohort analysis was performed. Patients were retrieved using a query in our medical database for the words 'cough' and 'gabapentin' in 2011. Patients without a clear etiology of cough despite having performed a stepwise diagnostic approach, were included. Medical records of these patients were analyzed. A telephonic survey was performed and patients were asked to retrospectivally rate their cough when they attended the outpatient clinic. They were then asked to rate their cough after treatment with gabapentin. A scale from one to ten was used to score cough severity. They were also questioned about the triggers inducing cough. To evaluate the cough severity score, the results were correlated with questions of the Leicester Cough Questionnaire.</p><p><strong>Results: </strong>We recruited 51 patients (87% female) with a mean age of onset of 47 years (± 14 y) and an average cough duration of 48 months. The most frequently reported cough triggers included change of temperature (57%), talking (49%) and odours (45%). In 67% of patients, the urge to cough was located in the throat area. Thirty-five patients effectively took the prescribed gabapentin. The average improvement in cough score was 2.8/10 (p<0.0001). Of the 35 patients, 20 achieved improvement of their cough symptoms. Responders had a higher pre-treatment cough severity score (p=0.02) and were more likely to have a history of pre-cough airway infection (p=0.04). Current cough severity score negatively correlated with the Leicester Cough Questionnaire scores (p=0.05).</p><p><strong>Conclusion: </strong>Chronic idiopathic cough were predominantly middle-aged women, frequently reporting various cough triggers. We also demonstrated that gabapentin can significantly improve cough in these patients. Responders tend to have higher pre-treatment severity scores and have a history of an airway infection.</p>","PeriodicalId":10747,"journal":{"name":"Cough (London, England)","volume":"8 1","pages":"9"},"PeriodicalIF":0.0000,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1745-9974-8-9","citationCount":"31","resultStr":"{\"title\":\"A cohort description and analysis of the effect of gabapentin on idiopathic cough.\",\"authors\":\"Charlotte Van de Kerkhove,&nbsp;Pieter C Goeminne,&nbsp;Pascal Van Bleyenbergh,&nbsp;Lieven J Dupont\",\"doi\":\"10.1186/1745-9974-8-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Unlabelled: </strong></p><p><strong>Background: </strong>Chronic idiopathic cough (known as cough hypersensitivity syndrome) is defined by cough in the absence of an identifiable cause. Gabapentin has been suggested as a treatment but evidence is scarce. The aim of our study was to describe the clinical features of patients with unexplained chronic cough and to investigate the effect of gabapentin (600 mg twice a day for a minimal duration of 4 weeks) in reducing cough symptoms.</p><p><strong>Methods: </strong>A patient cohort analysis was performed. Patients were retrieved using a query in our medical database for the words 'cough' and 'gabapentin' in 2011. Patients without a clear etiology of cough despite having performed a stepwise diagnostic approach, were included. Medical records of these patients were analyzed. A telephonic survey was performed and patients were asked to retrospectivally rate their cough when they attended the outpatient clinic. They were then asked to rate their cough after treatment with gabapentin. A scale from one to ten was used to score cough severity. They were also questioned about the triggers inducing cough. To evaluate the cough severity score, the results were correlated with questions of the Leicester Cough Questionnaire.</p><p><strong>Results: </strong>We recruited 51 patients (87% female) with a mean age of onset of 47 years (± 14 y) and an average cough duration of 48 months. The most frequently reported cough triggers included change of temperature (57%), talking (49%) and odours (45%). In 67% of patients, the urge to cough was located in the throat area. Thirty-five patients effectively took the prescribed gabapentin. The average improvement in cough score was 2.8/10 (p<0.0001). Of the 35 patients, 20 achieved improvement of their cough symptoms. Responders had a higher pre-treatment cough severity score (p=0.02) and were more likely to have a history of pre-cough airway infection (p=0.04). Current cough severity score negatively correlated with the Leicester Cough Questionnaire scores (p=0.05).</p><p><strong>Conclusion: </strong>Chronic idiopathic cough were predominantly middle-aged women, frequently reporting various cough triggers. We also demonstrated that gabapentin can significantly improve cough in these patients. Responders tend to have higher pre-treatment severity scores and have a history of an airway infection.</p>\",\"PeriodicalId\":10747,\"journal\":{\"name\":\"Cough (London, England)\",\"volume\":\"8 1\",\"pages\":\"9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1186/1745-9974-8-9\",\"citationCount\":\"31\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cough (London, England)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/1745-9974-8-9\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cough (London, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/1745-9974-8-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 31

摘要

背景:慢性特发性咳嗽(又称咳嗽过敏综合征)是指没有明确病因的咳嗽。加巴喷丁已被建议作为一种治疗方法,但证据不足。本研究的目的是描述不明原因慢性咳嗽患者的临床特征,并探讨加巴喷丁(600 mg,每天两次,最少持续4周)减轻咳嗽症状的效果。方法:采用患者队列分析。2011年,在我们的医疗数据库中查询“咳嗽”和“加巴喷丁”,检索患者。尽管采用了逐步诊断方法,但没有明确病因的患者也被纳入研究。对这些患者的医疗记录进行分析。进行了电话调查,并要求患者在门诊就诊时对他们的咳嗽进行回顾性评分。然后,他们被要求对加巴喷丁治疗后的咳嗽进行评分。咳嗽的严重程度用1到10来评分。他们还被问及引起咳嗽的诱因。为了评估咳嗽严重程度评分,结果与莱斯特咳嗽问卷的问题相关。结果:我们招募了51例患者(87%为女性),平均发病年龄为47岁(±14岁),平均咳嗽时间为48个月。最常见的咳嗽诱因包括体温变化(57%)、说话(49%)和气味(45%)。在67%的患者中,咳嗽冲动位于喉咙区域。35名患者有效服用了加巴喷丁。结论:慢性特发性咳嗽以中年妇女为主,经常报告各种咳嗽诱因。我们还证明加巴喷丁可以显著改善这些患者的咳嗽。应答者往往有较高的治疗前严重程度评分,并有气道感染史。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
A cohort description and analysis of the effect of gabapentin on idiopathic cough.

Unlabelled:

Background: Chronic idiopathic cough (known as cough hypersensitivity syndrome) is defined by cough in the absence of an identifiable cause. Gabapentin has been suggested as a treatment but evidence is scarce. The aim of our study was to describe the clinical features of patients with unexplained chronic cough and to investigate the effect of gabapentin (600 mg twice a day for a minimal duration of 4 weeks) in reducing cough symptoms.

Methods: A patient cohort analysis was performed. Patients were retrieved using a query in our medical database for the words 'cough' and 'gabapentin' in 2011. Patients without a clear etiology of cough despite having performed a stepwise diagnostic approach, were included. Medical records of these patients were analyzed. A telephonic survey was performed and patients were asked to retrospectivally rate their cough when they attended the outpatient clinic. They were then asked to rate their cough after treatment with gabapentin. A scale from one to ten was used to score cough severity. They were also questioned about the triggers inducing cough. To evaluate the cough severity score, the results were correlated with questions of the Leicester Cough Questionnaire.

Results: We recruited 51 patients (87% female) with a mean age of onset of 47 years (± 14 y) and an average cough duration of 48 months. The most frequently reported cough triggers included change of temperature (57%), talking (49%) and odours (45%). In 67% of patients, the urge to cough was located in the throat area. Thirty-five patients effectively took the prescribed gabapentin. The average improvement in cough score was 2.8/10 (p<0.0001). Of the 35 patients, 20 achieved improvement of their cough symptoms. Responders had a higher pre-treatment cough severity score (p=0.02) and were more likely to have a history of pre-cough airway infection (p=0.04). Current cough severity score negatively correlated with the Leicester Cough Questionnaire scores (p=0.05).

Conclusion: Chronic idiopathic cough were predominantly middle-aged women, frequently reporting various cough triggers. We also demonstrated that gabapentin can significantly improve cough in these patients. Responders tend to have higher pre-treatment severity scores and have a history of an airway infection.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A crossover randomized comparative study of zofenopril and ramipril on cough reflex and airway inflammation in healthy volunteers. Standardized method for solubility and storage of capsaicin-based solutions for cough induction. On the definition of chronic cough and current treatment pathways: an international qualitative study. Effect of acid suppression therapy on gastroesophageal reflux and cough in idiopathic pulmonary fibrosis: an intervention study. Severity of cough in idiopathic pulmonary fibrosis is associated with MUC5 B genotype.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1